Prevention of hereditary haemoglobinopathies in the Netherlands;Preventie van erfelijke hemoglobinopathieën in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 39, 2006, Pages 2137-2141

  Giordano, P C ^a   Harteveld, C L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; DISEASE SEVERITY; FIRST TRIMESTER PREGNANCY; GENERAL PRACTITIONER; GENETIC DISORDER; HEALTH CARE; HEALTH CENTER; HEALTH SERVICE; HEMOGLOBINOPATHY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MEDICAL INFORMATION; NETHERLANDS; PATIENT COUNSELING; RISK FACTOR;

GENETIC SCREENING; GENETIC TESTING; HEMOGLOBINOPATHIES; HEMOGLOBINS; HETEROZYGOTE DETECTION; HUMANS; NETHERLANDS; PRIMARY PREVENTION;

EID: 33750016024     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of hemoglobin. Cambridge: Cambridge University Press; 2001.
2. Beers EJ van, Peters M, Biemond BJ. Pathofysiologie en behandeling van sikkelcelziekte. Ned Tijdschr Geneeskd. 2005;149:1144-9,
3. Bianco I, Graziani B, Lerone M, Congedo P, Ponzini D, Braconi F, et al. A screening programme for the prospective prevention of Mediterranean anaemia in Latium: results of seven years' work. J Med Genet. 1984;21:268-71.
4. Wieringa KJJ. Neonatale screening op sikkelcelziekte. Ned Tijdschr Geneeskd. 1997;141:184-7.
5. Giordano PC. Hemoglobinopathieën in Nederland. Diagnostiek, epidemiologie en preventie [proefschrift]. Leiden: Universiteit Leiden: 1998.
6. Giordano PC, Breuning MH. Van gen naar ziekte; van hemoglobine-genen naar thalassemie en sikkelcelanemie. Ned Tijdschr Geneeskd. 2000;144:1910-3.
7. Giordano PC, Bouva MJ, Harteveld CL. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in the Netherlands. Hemoglobin. 2004;28:287-96.
8. Fodde R, Losekoot M, Giordano PC, Harteveld CL, Bernini LF. Polymerase chain reaction: applications for beta-thalassemia diagnosis. In: Proceedings of the 30th Dutch Federation Meeting. Maastricht: Dutch Foundation Federation of Medical Scientific Societies; 1989.
9. Giordano PC, Harteveld CL, Heister JGAM, Batelaan D, Delft P van, Plug R, et al. The molecular spectrum of beta-thalassemia and abnormal hemoglobins in the allochthonous and autochthonous Dutch population. Community Genet. 1998;1:243-51.
10. Baars MJ, Henneman L, Kate LP ten. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med. 2005;7:605-10.
11. Giordano PC, Harteveld CL, Bernini LF. The need for diagnosis and prevention of hemoglobinopathies in Northern Europe: the Dutch situation. Haematologica. 1999;84:103-4.
12. Giordano PC, Harteveld CL. Standard protocol for hemoglobinopathy trait diagnostics using automated HPLC, preceeded by a simple pre-selective flowchart. The 9th International conference on thalassemia and hemoglobinopathies. Congres Proceedings P049. Palermo: Thalassemia International Federation; 2003.
13. Giordano PC, Smit JW, Herruer M, Huisman W, Pouwels JGJ, Verhoef N, et al. Dragerschapsdiagnostiek en preventie van sikkelcelziekte en thalassemia major. Aanbevelingen van de werkgroep hemoglobinopathieën. Nederlands Tijdschrift voor Klinische Chemie. [ter perse].
14. Wijkamp C, Harteveld CL, Giordano PC. Quality control in laboratory hemoglobinopathies diagnostics in the Netherlands. CCLM. 2005: 3446.
15. Harteveld KL, Losekoot M, Fodde R, Giordano PC, Bernini LF. The involvement of Alu repeats in recombination events at the alpha-globin gene cluster: characterization of two alphazero-thalassaemia deletion breakpoints. Hum Genet. 1997;99:528-34.
16. Wijk MAM van, Mel M, Muller PA, Silverentand WGJ, Pijnenborg L, Kolnaar BGM, et al. NHG-standaard Anemie. Huisarts Wet. 2003;46:3-11.
17. Olney RS. Preventing morbidity and mortality from sickle cell disease. A public health perspective. Am J Prev Med. 1999;16:116-21.
18. Giordano PC. Toward state of the art neonatal screening and primary prevention of the hemoglobinopathies in the Netherlands. Den Haag: ZonMw; 2006.
19. Giordano PC, Plancke A, Meir CA van, Janssen CA, Kok PJ, Rooijen-Nijdam IH van, et al. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in the Netherlands: a pilot study. Prenat Diagn. 2006;26:719-24.
20. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull World Health Organ. 1995;73:375-86.
21. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004;329:1134-7.
22. Longinotti M, Pistidda P, Oggiano L, Guiso L, Frogheri L, Dore F, et al. A 12-year preventive program for beta-thalassemia in Northern Sardinia. Clin Genet. 1994;46:238-43.
23. Maffei L, Foglietta E, Cappabianca MP, Lerone M, Mastropietro F, Bianco I. The prevention of the thalassemia maior: emergent problems. Haematologica. 2002;87:ELT44.
24. Lena-Russo D, Erny N, Serradimigni F, Badens C, Aubinaud M, Merono F, et al. Maladies genetiques de l'hemoglobine. Prevention dans les centres de planification et d'education familiale de la protection maternelle et infantile a Marseille. Presse Med. 1996;25:151-3.
25. Ghanei M, Adibi P, Movahedi M, Khami MA, Ghasemi RL, Azarm T, et al. Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan. Public Health. 1997;111:153-6.
26. Levin M. Screening Jews and genes: a consideration of the ethics of genetic screening within the Jewish community: challenges and responses. Genet Test. 1999;3:207-13.
27. Kuliev A, Rechitsky S, Verlinsky O, Tur-Kaspa I, Kalakoutis G, Angastiniotis M, et al. Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod Biomed Online. 2005;11:302-70.
28. Nieuwe mogelijkheden voor embryoselectie bij erfelijke aandoeningen. Den Haag: Gezondheidsraad; 2006.